Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hirokazu Abe

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Urologic Oncology|January 5, 2023
Percutaneous cryoablation versus partial nephrectomy for cT1b renal tumors: An inverse probability weight analysisKoichi Aikawa, Takafumi Yanagisawa, Wataru Fukuokaya, et al.
International Journal of Oncology|August 13, 2013
A great option for elderly patients with locally invasive bladder cancer, BOAI-CDDP-radiation (OMC regimen)Haruhito Azuma, Teruo Inamoto, Kiyoshi Takahara, et al.
Targeted Oncology|January 5, 2021
Impact of Dose-Effect in Smoking on the Effectiveness of Pembrolizumab in Patients with Metastatic Urothelial CarcinomaWataru Fukuokaya, Takahiro Kimura, Takafumi Yanagisawa, et al.
International Journal of Clinical Oncology|March 2, 2024
Association between comorbidities and survival in patients with metastatic urothelial carcinoma treated with pembrolizumabMasaki Hashimoto, Wataru Fukuokaya, Takafumi Yanagisawa, et al.
Clinical Genitourinary Cancer|April 21, 2024
Radiographic Progression at Castration-Resistant Prostate Cancer Diagnosis: A Prognostic Indicator of Metastatic Hormone-Sensitive Prostate CancerKojiro Tashiro, Shoji Kimura, Shunsuke Tsuzuki, et al.
Urologic Oncology|March 29, 2022
Effectiveness of pembrolizumab in patients with urothelial carcinoma receiving proton pump inhibitorsWataru Fukuokaya, Takahiro Kimura, Kazumasa Komura, et al.
Japanese Journal of Clinical Oncology|July 23, 2021
Prognostic model with alkaline phosphatase, lactate dehydrogenase and presence of Gleason pattern 5 for worse overall survival in low-risk metastatic hormone-sensitive prostate cancerShunsuke Tsuzuki, Shota Kawano, Wataru Fukuokaya, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Urologic Oncology|January 5, 2023
Percutaneous cryoablation versus partial nephrectomy for cT1b renal tumors: An inverse probability weight analysisKoichi Aikawa, Takafumi Yanagisawa, Wataru Fukuokaya, et al.
International Journal of Oncology|August 13, 2013
A great option for elderly patients with locally invasive bladder cancer, BOAI-CDDP-radiation (OMC regimen)Haruhito Azuma, Teruo Inamoto, Kiyoshi Takahara, et al.
Targeted Oncology|January 5, 2021
Impact of Dose-Effect in Smoking on the Effectiveness of Pembrolizumab in Patients with Metastatic Urothelial CarcinomaWataru Fukuokaya, Takahiro Kimura, Takafumi Yanagisawa, et al.
International Journal of Clinical Oncology|March 2, 2024
Association between comorbidities and survival in patients with metastatic urothelial carcinoma treated with pembrolizumabMasaki Hashimoto, Wataru Fukuokaya, Takafumi Yanagisawa, et al.
Clinical Genitourinary Cancer|April 21, 2024
Radiographic Progression at Castration-Resistant Prostate Cancer Diagnosis: A Prognostic Indicator of Metastatic Hormone-Sensitive Prostate CancerKojiro Tashiro, Shoji Kimura, Shunsuke Tsuzuki, et al.
Urologic Oncology|March 29, 2022
Effectiveness of pembrolizumab in patients with urothelial carcinoma receiving proton pump inhibitorsWataru Fukuokaya, Takahiro Kimura, Kazumasa Komura, et al.
Japanese Journal of Clinical Oncology|July 23, 2021
Prognostic model with alkaline phosphatase, lactate dehydrogenase and presence of Gleason pattern 5 for worse overall survival in low-risk metastatic hormone-sensitive prostate cancerShunsuke Tsuzuki, Shota Kawano, Wataru Fukuokaya, et al.
Pageof 8